CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 105 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $40,000 | +48.1% | 22,000 | +61.8% | 0.00% | – |
| Q1 2022 | $27,000 | -86.1% | 13,595 | -68.7% | 0.00% | – |
| Q3 2021 | $194,000 | -19.5% | 43,485 | +4.8% | 0.00% | -100.0% |
| Q2 2021 | $241,000 | +153.7% | 41,485 | +108.8% | 0.00% | – |
| Q4 2020 | $95,000 | -56.2% | 19,870 | +523.7% | 0.00% | -100.0% |
| Q4 2017 | $217,000 | -13.5% | 3,186 | +4.7% | 0.00% | -50.0% |
| Q3 2017 | $251,000 | +20.7% | 3,042 | -6.9% | 0.00% | 0.0% |
| Q1 2017 | $208,000 | – | 3,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |